Modifiable Risk Factors and Residual Risk Following Coronary Revascularization

Modifiable Risk Factors and Residual Risk Following Coronary Revascularization

Objective: To ensure compliance with optimal secondary prevention strategies and document the residual risk of patients following revascularization, we established a postrevascularization clinic for risk-factor optimization at 1 year, with outcomes recorded in a web-based registry. Although coronary...

Full description

Bibliographic Details
Main Authors: Trevor Simard, MD, Richard G. Jung, PhD, Pietro Di Santo, MD, David T. Harnett, MD, MSc, Omar Abdel-Razek, MD, F. Daniel Ramirez, MD, MSc, Pouya Motazedian, MD, Simon Parlow, MD, Alisha Labinaz, BSc, Robert Moreland, MD, Jeffrey Marbach, MBBS, MS, Anthony Poulin, MD, Amos Levi, MD, Kamran Majeed, MD, Paul Boland, MD, PhD, Etienne Couture, MD, Kiran Sarathy, MD, Steven Promislow, MD, Juan J. Russo, MD, Aun Yeong Chong, MD, Derek So, MD, Michael Froeschl, MD, Alexander Dick, MD, Marino Labinaz, MD, Michel Le May, MD, David R. Holmes, Jr., MD, Benjamin Hibbert, MD, PhD
Format: Article
Language:English
Published: Elsevier 2021-12-01
Series:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S254245482100134X

Internet

http://www.sciencedirect.com/science/article/pii/S254245482100134X

Similar Items